You are here

Heart Failure

 - Heart Failure - Don't use until 3/1/12

Although most people are aware of heart failure, they often do not understand the signs and symptoms of the disease, according to an American Heart Association poll released on June 15.

 - hospital_room

Patients using cardiac resynchronization therapy (CRT) devices equipped with an algorithm were significantly less likely to be readmitted to hospitals within 30 days following discharge for heart failure and all other causes. 

 - HeartWare system

The FDA announced another Class I recall for HeartWare, this time citing damaged alignment guides or connection pins in its ventricular assist system that potentially could cause the pump to stop. The recall affects 1,763 devices.

 - hospitalist and patient

Patients with acute decompensated heart failure who had severe congestion during and after hospitalization had an increased risk of mortality and morbidity, according to a post-hoc analysis of two clinical trials.

 - older men

After one and four years, older patients with heart failure were more likely to be alive if they received cardiac resynchronization therapy with defibrillator (CRT-D) compared with a group who received only an implantable cardioverter-defibrillator (ICD), according to a registry analysis.

 

More Stories

More than 10% of patients hospitalized for HF have worsening symptoms

Approximately 10 percent to 15 percent of patients had worsening heart failure or died within five days of being admitted into a hospital for acute heart failure, according to a pooled analysis of clinical trials.

Wine may improve spirits but not outcomes for heart failure patients

Moderate wine consumption may lighten the outlook for patients with chronic heart failure but it may not make any difference in long-term outcomes, based on results from a large Italian study.

Cognitive decline is common after LVAD implantation

Nearly one-third of patients had cognitive decline one year after undergoing left ventricular assist device (LVAD) implantation for advanced heart failure, according to an analysis of a large, multicenter, observational registry

Low health literacy associated with increased risk of death in acute HF patients

Patients with acute heart failure had an increased risk of all-cause mortality after being discharged from the hospital if they had a low level of health literacy, according to a retrospective study. After adjusting for various factors, the risk of death for patients with low health literacy was 32 percent higher than for patients with higher health literacy.

Hodgkin lymphoma survivors at high risk of cardiovascular diseases

People with Hodgkin lymphoma have a high risk for various cardiovascular diseases for decades after their initial diagnosis, according to a retrospective cohort study.

Heart failure incidence dips 37.5% over 10 years

The incidence of heart failure dropped steeply over a decade in a population-based study, and while hospitalization rates remained steady over time, causes shifted from cardiovascular to noncardiovascular.

FDA approves ivabradine for heart failure patients

The FDA approved ivabradine to reduce the risk of hospitalization in patients with heart failure. The agency had expedited its evaluation of the drug under its priority review program.

FDA panel favors heart failure warning on saxagliptin’s labeling

An FDA advisory panel recommended that labeling for the diabetes drug saxagliptin include a warning about a risk of heart failure. The panel determined that the drug’s overall cardiovascular risk was acceptable.

Phenomapping analysis identifies groups of heart failure patients

A phenomapping analysis of patients hospitalized for heart failure found that heart failure with preserved ejection fraction is a heterogeneous disorder and contains mutually exclusive groups with similar characteristics.

Statement on treating patients with hypertension and heart failure

The statement from the American Heart Association (AHA), American College of Cardiology (ACC) and American Society of Hypertension (ASH) updated guidelines from 2007.

Analysis shows 15% of HeartWare recipients develop gastro bleeding

Approximately 15 percent of patients with advanced heart failure experienced gastrointestinal bleeding after receiving the HeartWare Ventricular Assist Device System. However, none of the events impacted survival, and no surgical intervention was needed.

Stroke risk may be high for some patients with heart failure but no a-fib

While guidelines warn against giving anticoagulation to patients with heart failure but without atrial fibrillation, there may be some evidence that a subgroup of these patients may be at increased risk for stroke and could benefit from additional therapy.

Caregivers of destination LVAD patients benefit from support, too

Patients aren’t the only ones impacted by destination therapy left ventricle assist device (LVAD) implants. Caregivers should be part of decision-making and they need support and tools to help them process the change, according to a study.

Sunshine Heart suspends trial after reports of deaths

Sunshine Heart put its U.S. pivotal clinical trial on hold after receiving reports of four deaths among the study’s participants.

HeartWare recall targets clinical trial participants

HeartWare International issued a voluntary recall in the U.S. of older controllers that were distributed during clinical trials.

Donor heart acceptance rate drops as demand rises

Despite growing waiting lists and national efforts to increase the use of available donor organs, the rate of hearts accepted for transplantation has decreased significantly since 1995, a study found.

Cardiologist-driven heart failure care may improve short-term outcomes

Patients with acute decompensated heart failure may benefit more from care by a cardiologist than a non-cardiologist, according to a study published in the February issue of the American Journal of Cardiology.

Review of hospital care finds high rates of IV fluids given for acute heart failure

Early care with intravenous (IV) fluid is not recommended by guidelines for patients with acute decompensated heart failure. However, 11 percent of patients in a study published Feb. 1 in the Journal of the American College of Cardiology: Heart Failure received IV fluid and diuretics in the first two days of hospitalization. 

Pigskins & not porking out

Heart failure is one of the most expensive diseases in the U.S., with many boomerang patients and a stinging financial penalty from Medicare for hospitals with higher than expected 30-day readmissions. It doesn’t need to be that way.

Listen up: Heart failure tool helps ID barriers to self-care

Putting a stop to boomerang heart failure readmissions may require a sympathetic ear in the emergency department (ED). One pilot test has shown that it is possible to identify patients’ barriers to self-care, even in a busy ED setting.